Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-09

Clinical Trial Update: Myocardial Hemodynamic Effects of Levosimendan [Phase 2]

View source ↗

Summary

Phase 2 trial results indicate myocardial hemodynamic effects of levosimendan in patients with heart failure; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: University of Utah | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2010-06-09